Abstract Background and aim: Breast cancers (BCs) involve the left side (LS) more than the right side (RS). Among the Egyptians, neither BC laterality nor its association with demographic factors, tumor locations, treatments and outcomes were previously reported. Patients and methods: Laterality was analyzed among 5459 BCs from the Gharbiah populationbased cancer registry covering >5% of the Egyptian population. Cox proportional model was used to assess the independent effect of stage, ER, and laterality on overall survival (OS). Results: In Egypt, BCs involve LS more than RS with LS-to-RS ratio (LRR) of 1.16. LS predominance was evident among men and women and both younger (<45 years) and older patients. HER2 over-expression and ductal cancers were significantly more in RSBCs while lobular cancers were significantly more in LSBCs. There were no significant differences in localization within the breast between LSBCs and RSBCs (p = 0.51). LS predominance was noticed across all subgroups except in patients with HER2 positive tumors (LRR = 0.63; p = 0.02). OS was significantly better in stage II and ER positive tumors than stage III and ER negative tumors. Despite OS of LSBCs being generally lower than RSBCs, this was not statistically significant. The significant impact of stage on OS was lost in LSBCs. Conclusions: Among Egyptian patients, the left breast is at greater risk of cancer than the right one. Despite right-sided tumors seemed more aggressive, Left-sided ones tend to confer worse survival than right-sided tumors.
Introduction
Breast cancer (BC) is the most common female malignancy accounting for 22.9% and 37.7% of all female cancers worldwide and in Egypt, respectively [1] [2] [3] . BC in Egypt carries an unfavorable prognosis with 29% mortality and 3.7:1 incidence to mortality ratio [1] .
BC was consistently reported to afflict the left breast more than the right one [4] [5] [6] [7] [8] [9] . Despite the causes for left-sided predominance (LSP) being unclear, it may reflect etiologic factors not yet recognized or understood [10] . Increased trauma [4, 6] , lactation dysfunction of the left breast [11] and breast-feeding patterns [12] were suggested but they lack the supporting evidence. As the left breast is slightly larger than the right due to hemodynamic asymmetry, breast size was suggested as an explanation for LSP [4, 6, 8] . However, the minimal increase in size does not explain the magnitude of increased cancer risk in the left compared to the right breast [6] . Furthermore, breast size was proved not to be associated with BC risk [13] . Thus, the breast parenchyma mass, or mammary gland cell mass, may be a better predictor BC risk than the size [14] . It was also suggested that LSP may reflect easier self-detection by the right-handed patients that represent the majority of the population [6, 15] . However, this was not confirmed [9, 16] .
LSP was mentioned to increase with age [6, 8, 9] and differs with population race and ethnicity [10, 12, 13, 16] . In a small study, both total number and the number of involved axiliary lymph nodes (ALNs) were smaller in left-sided BCs than the right-sided ones [17] .
Although the excess of left-sided tumors is not large and does not appear to have major clinical implications [18] , breast or chest wall irradiation leads to higher radiation doses to the heart in left-sided tumors compared to the right side [19] . This might result in a greater cardiovascular mortality following irradiation of the left breast when compared with the right breast [20, 21] . Thus, caution to cardiac exposure and new irradiation techniques that limit that exposure should be used in left sided tumors. Also, the sequential or concomitant administration of cardiotoxic drugs such as anthracyclines, cyclophosphamide and trastuzumab has to be properly planned [19] .
It was reported that women living in Israel had various laterality patterns where those born in the Middle East and Asia had more right-sided tumors and those born in other regions had left-sided tumors. The survival was not different at any stage among right and left-sided tumors [22] . To the best of our knowledge, neither laterality of BC among Egyptian patients nor its association with various clinico-pathological characteristics, treatments and disease outcomes have been reported.
Patients and methods
All cases of breast cancers diagnosed from 1999 to 2007 were identified through the Gharbiah Population-based Cancer Registry (GPBCR), covering >5% of the Egyptian population. The analyses were based on 5459 cases of invasive breast carcinomas. Subjects with non-invasive cancer (112 cases), bilateral cancer (48 cases) or unknown laterality (432 cases), other noncarcinoma histology (164 cases) or unspecified malignancy (409 cases) were excluded. The association between laterality and treatments and their outcomes was assessed in a group of 283 patients whose information was available.
Statistical analyses
All analyses were done using Microsoft ExcelÒ 2012 and SPSSÒ version 15. Chi squared test or Fisher's Exact test were used to compare right and left-sided BCs with other variables. Survival was assessed using the Kaplan Meier Method and groups were compared using the log-rank test. Cox proportional hazard model was used to assess the independent effect of stage, ER, PR and laterality on overall survival (OS). OS is defined as the time between diagnosis and death or last follow up. A probability (p) < 0.05 is considered statistically significant.
Results
Out of 5459 cases of invasive breast cancers (BCs), 2928 cases (53.64%) were left-sided and 2531 cases were right-sided (46.36%). Overall, the left to right ratio (LRR) was 1.16. LRR ranged between 1.04 and 1.27 (Table 1 ). There was no significant association between overall LRR and the year (p = 0.56). Collectively and during individual years, left-sided predominance (LSP) was also noted in males and females despite the LRR was generally but non-significantly higher in males than females (p = 0.40). Reversed LRR (i.e. right-sided predominance; RSP) was noted during the years 2003 and 2004. However, the numbers of male BCs were very small to consolidate the finding.
The median age of patients with right-sided tumors was 49 years (IQR, 42-56) compared to 50 years (IQR, 43-57) for those with left-sided tumors and this was not statistically significant (p = 0.33). The median age of patients with left and right sided tumors increased with time (Fig. 1A) . Leftsided predominance was maintained across most various age groups and in the younger (<45 years) compared to the older women (Table 2) . Nevertheless, women <25 years had RSP and the numbers in this category were generally small. Laterality differences according to age groups were not statistically significant (p = 0.28).
Left-sided tumors involved the central and lower-inner quadrants in 15.1% and 9.5%, respectively compared to 13.6% and 8.5% for right-sided tumors. Right-sided BCs involved the upper-outer quadrant in 46.6% compared to 44.3% for left sided tumors (p = 0.51; Table 3 ). Apart from decline of median tumor size in the year 2000, the median tumor size for right and left BCs was stable at around 4 cm (Fig. 1B) . Apart from an initial drop in the year 2000, the median number of positive axillary lymph nodes (ALNs) slightly fluctuated around 5 (Fig. 1C) . The total number of dissected ALNs was not statistically different between right and leftsided BCs and fluctuated around the number 13 ( Fig. 1D) .
BC Laterality was significantly associated with tumor histology (p 6 0.001) where right-sided tumors had more ductal (91.7% vs. 88.5%) and left-sided tumors had more lobular cancers (8.7% vs. 5.1%). BC laterality was also associated with HER2 expression (p = 0.02) where right-sided tumors had more score 3 (33.9% vs. 21.3% and left-sided tumors had more score 0-2 (78.7% vs. 66.1%; Table 4 ). LSP was noticed across all subgroups except in tumors with HER2 score of 3 and T4 tumors where right-sided tumors predominated (Table 4) . TNM and SEER tumor stages and consequently different lines of therapies were not statistically different between right-and left-sided BCs. Treatments were encountered in comparable percentage in left and right-sided tumors (Table 6 ) (p > 0.5 for all).
To associate the laterality with treatments and their outcomes, we selected a subgroup of patients from the same database with complete information on treatments and survival. All had node-positive disease (N+) and were negative for metastases (M0) i.e. stage II and III. This group counted 283 BCs representing 5.2% of the GPBCR cases. The characteristics of this group are shown in Table 5 which were largely similar to those of the GPBCR BC population. Overall, there was LSP with a LRR of 1.05. The LSP in this patients' subgroup was less marked than the GPBCR cases as these are markedly smaller. However, right-sided predominance was noted in HER2 score of 3 + and in T4 tumors similar to GBPCR patients. Various treatment options detailed in Table 6 are not significantly different in left and right-sided tumors (Table 6) .
After a median follow up of 25 months (range, 1-67 months), 31 patients were dead; 17 patients with left sided tumors and 14 patients with right sided tumors. The median OS was not reached. The 2-and 5-year OS rates were 88.9% and 81.42% respectively. OS was significantly associated with TNM stage, ER, PR and hormonal therapy ( Table 7) . The 2-and 5-year OS rates for patients with left-sided tumors were 87.0% and 82.8% and for those with right-sided tumors were 90.8% and 80.5% (p = 0.607; Fig. 2 ).
For left-sided tumors, the 2-and 5-year OS rates for patients with stage II disease were 91% and 88% and for those with stage III were 85% and 79% (p = 0.366; Fig. 3A) . For right-sided tumors, The 2-and 5-year OS rates for patients with stage II were 100% and 86% and for those with stage III were 86% and 79% (p = 0.026; Fig. 3B ). For left-sided tumors, the 2-and 5-year OS rates for patients with ER negative tumors were 71% and 64% compared to 92% and 90% for ER positive tumors, respectively (p = 0.002). For right-sided tumors, the 2-and 5-year OS rates for patients with ER negative tumors were 82% and 76% compared to 96% and 76% for ER positive tumors, respectively (p = 0.042) (Fig. 4) . The variables which were significantly associated with OS using the log-rank test were entered into a stepwise Cox Proportional Hazard model. This model showed that only hormonal treatment was an independent predictor of OS (p = 0.002). The hazard of death in patients who did not receive hormonal treatment was 3.5 times the hazard in patients who received hormonal therapy (CI: 1.6-7.4).
Discussion
This is the first report from Egypt and the second from the Middle East that reports on breast cancer laterality in a large number of patients using population based registry data. The earlier report [22] was more than 33 years ago and comments on patients diagnosed in 1960 through 1975 in Israel whose population is more diverse as it includes immigrants from many world regions and thus belongs to many racial and ethnic groups. Early on, many of the now-available breast cancer therapies were not known thus survival figures were generally poor and the impact of modern prognostic factors like ER and HER2 was not assessed. Our study includes a large number of population-based breast cancer patients that belong almost to one native race and assesses the impact of important prognostic and therapeutic factors. The previous findings of LSP of invasive BC [4] [5] [6] [7] [8] [9] [10] 22] are confirmed in the current study. Due to the small numbers of non-invasive carcinoma in GPBCR, we elected not include them in the analysis and limit the analysis to invasive BCs that we thought would be a homogenous group. However, many authors showed that LSP is noted for non-invasive as well as invasive BCs [5, 8, 10] .
The left to right ratio (LRR) in the current study was 1.12 compared to 1.05 in US [9, 10] [7] . Reasons for the differences in BC laterality as well the LRR among various world regions are largely unknown and may reflect unidentified risk factors [10] . However, there is an association of the magnitude of LSP and sample size whereas studies with larger samples [8] [9] [10] 22] had lower LSP than those with a larger sample size [6, 7] .
In this retrospective study, we could not associate the laterality to the presumed reasons as data on reproductive history, trauma, lactation, breast size/parenchymal mass or handedness were not available through the GPBCR database. In the current study, we could not study the effect of race on BC laterality as race data were lacking in GPBCR. However, the population of Gharbiah District is rather homogenous and consists of natives [23] . Our finding of LSP contradicts with that from Israel that showed that patients born in the Middle East or in Asian countries had a predominance of right sided tumors and those born elsewhere had LSP [22] . However, the latter report involved a small number of patients in this category. Laterality reports that involved thousands of patients in different race and ethnicity populations showed a consistent LSP [8] [9] [10] 22] . Like females, males showed LSP throughout the 9-year study period with a LRR of 1.46. This is similar to [4] [5] [6] [7] [8] 10] . In agreement with Perkins et al. [10] , we have shown that age was not significantly associated with laterality. Our finding of the predominance of right-side tumors in patients below 25 years needs further verification as the numbers in this category are small. In agreement with Perkins et al. [10] , but contradicting with others [4, [6] [7] [8] , we showed that LSP was not different between patients aged <45 years or >45 years. However, the studies that showed this association were relatively smaller trials [4, [6] [7] [8] .
We have shown that the LSP mainly involved the central and upper inner quadrants. This is different from the LSP in the inner half reported by Perkins et al. [10] . The reasons for this are unknown as there are no known physiological, pathological, or immunological differences between the lower, but not upper, left and right breasts that would explain for these finding. However, it should be noted that up to 25% of cases in the current had undetermined breast localization. If these were known, figures may have changed.
For the first time, we studied the relation between laterality and receptor status. Compared to left-sided tumors, right-sided ones were more likely to have HER2 score of 3+ (p = 0.02) and to have T4 disease (p = 0.24). These novel findings had no explanation and may need further confirmation. If proven, this may mean that left tumors may be less aggressive than right ones.
In the current study, stage III and ER negativity conferred significantly lower survival than stage II and ER positivity. We showed that OS was generally, yet non-significantly, poorer in left than right-sided tumors. However, left sided localization abolished the apparent significant difference between stages III and II observed in the total group as well as in the rightside localization. Thus, the finding by Melnik et al. [22] that OS was not different between right-and left-sided breast tumors at any stage partially contradicts our finding. The mentioned trial included patients during the time between 1960 and 1975 when modern therapies available today were not widely used. This inferred a poor prognosis of their patients compared to the current study. The loss of survival benefit in stage II compared to stage III tumors of the left side may be explained by the fact that all of the patients in the current study were node positive and most of them received radiotherapy with possible damage to the heart. Cardiac deaths in left sided tumors are well-recognized [19] . Thus, poor survival of left-sided tumors may not be related to the site per se but rather to the toxicity of radiation to this site that entails more exposure of the heart. However, cause-specific morality was not ascertained in most of our patients.
In conclusion, predominance of left-sided breast tumors over the right is confirmed among Egyptian patients. Rightsided tumors had more tendencies to afflict very young patients, to present as T4 and to be HER2 positive. Left-sided tumors tend to confer worse survival compared to right-sided tumors, possibly related to radiation toxicity to the heart in left-sided cancers. Further research to explain the reasons for these differences is warranted.
